Skip to main content
RPbio Inc. logo

RPbio Inc. — Investor Relations & Filings

Ticker · 314140 ISIN · KR7314140005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2025-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 314140

About RPbio Inc.

https://rpbio.co.kr/html/en/main.php

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Recent filings

Filing Released Lang Actions
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 알피바이오' (RP Bio Inc.) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (Annual General Meeting) for the company 'Alpibio'. It details the approval of financial statements, election of directors, and other resolutions passed during the meeting held on March 31, 2025. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the official outcomes of shareholder votes.
2025-03-31 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a formal 'Business Report' (사업보고서) for the fiscal year 2024 (Jan 1, 2024 to Dec 31, 2024) submitted to the Financial Supervisory Service and Korea Exchange. It contains comprehensive company information, financial data, management discussion, and governance details. This is the standard Korean regulatory filing equivalent to a 10-K. FY 2024
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data, and confirms the receipt of the audit report from the external auditor (Hyundai Accounting Corp). While it contains financial data, it is a summary disclosure of the audit results rather than the full annual report (10-K) or a standalone audit report document (AR). According to the 'Menu vs Meal' rule, this is a formal regulatory announcement of the audit report's availability and key findings, which fits the 'Regulatory Filings' (RNS) category as it serves as a standard disclosure notice in the Korean market. FY 2024
2025-03-20 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Alpi Bio. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements and the appointment of a director. This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2025-03-14 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for RP Bio. It contains the agenda for the upcoming Annual General Meeting (AGM), including items for approval such as financial statements, director appointments, and remuneration limits. It also includes management information and business reports typically provided to shareholders in preparation for the meeting. This aligns with the definition of AGM Information (AGM-R), which covers materials shared for the Annual General Meeting.
2025-03-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.